Cargando…
Preclinical Studies in Anti-Trypanosomatidae Drug Development
The trypanosomatid parasites Trypanosoma brucei, Trypanosoma cruzi and Leishmania are the causative agents of human African trypanosomiasis, Chagas Disease and Leishmaniasis, respectively. These infections primarily affect poor, rural communities in the developing world, and are responsible for trap...
Autores principales: | Perdomo, Cintya, Aguilera, Elena, Corvo, Ileana, Faral-Tello, Paula, Serna, Elva, Robello, Carlos, Wilkinson, Shane R., Yaluff, Gloria, Alvarez, Guzmán |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308625/ https://www.ncbi.nlm.nih.gov/pubmed/34358070 http://dx.doi.org/10.3390/ph14070644 |
Ejemplares similares
-
A Nature-Inspired Design Yields a New Class of Steroids Against Trypanosomatids
por: Aguilera, Elena, et al.
Publicado: (2019) -
Looking for combination of benznidazole and Trypanosoma cruzi-triosephosphate isomerase inhibitors for Chagas disease treatment
por: Aguilera, Elena, et al.
Publicado: (2018) -
Preclinical Studies and Drug Combination of Low-Cost Molecules for Chagas Disease
por: Aguilera, Elena, et al.
Publicado: (2022) -
Benznidazole Biotransformation and Multiple Targets in Trypanosoma cruzi Revealed by Metabolomics
por: Trochine, Andrea, et al.
Publicado: (2014) -
Author Correction: Extracellular vesicles carrying lactate dehydrogenase induce suicide in increased population density of Plasmodium falciparum in vitro
por: Correa, Ricardo, et al.
Publicado: (2020)